✦ LIBER ✦

Quantification of the Prentice Criteria for Surrogate Endpoints

✍ Scribed by John O'Quigley; Philippe Flandre

Book ID: 109223451
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 169 KB
Volume: 62
Category: Article
ISSN: 0006-341X
DOI: 10.1111/j.1541-0420.2006.00538.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate endpoints and emerging surroga

Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease

✍ Crystal M Rasnake; Paula R Trumbo; Therese M Heinonen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The Evaluation of Surrogate Endpoints

✍ Hans C. Van Houwelingen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Quantification of recurrence volumes aft

Quantification of recurrence volumes after endovascular treatment of cerebral aneurysm as surrogate endpoint for treatment stability

✍ Thorsten Ries; Karl Wegscheider; Asmus Wulff; Kristin Radelfahr; Dennis Säring; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 207 KB

Meta-analysis for the evaluation of surr

Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials

✍ Qian Shi; Daniel J. Sargent 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 254 KB

Screening for ovarian cancer: What are t

Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?

✍ Beth Y. Karlan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

The inability to identify relevant markers for presymptomatic screening in early stage or "preinvasive" ovarian cancer has plagued investigators and clinicians facing the problems of early detection. The characteristic late stage of disease at initial presentation has hindered our understanding of t

Surrogate endpoints in chemoprevention o

Surrogate endpoints in chemoprevention of breast cancer: Guidelines for evaluation of new biomarkers

✍ Susan G. Hilsenbeck; Gary M. Clark 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB